Elevance Health, Inc. (ELV)

NYSE: ELV · Real-Time Price · USD

392.54

-1.89 (-0.48%)

At close: Aug 31, 2026, 4:00 PM EDT

392.54

0.00 (0.00%)

After-hours: Aug 31, 2026, 7:30 PM EDT

Elevance Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	85,130	77,906	85,556	110,797	122,511	112,508
Market Cap Growth	22.03%	-8.94%	-22.78%	-9.56%	8.89%	40.89%
Enterprise Value	105,942	101,424	104,942	125,705	138,384	130,821

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	17.47	13.76	14.31	18.51	20.79	18.27
PS Ratio	0.42	0.39	0.48	0.65	0.78	0.81
PB Ratio	1.90	1.77	2.07	2.81	3.37	3.11
P/FCF Ratio	13.54	24.55	18.80	16.38	16.91	15.46
P/OCF Ratio	11.41	18.16	14.73	13.75	14.59	13.45

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	0.53	0.51	0.59	0.73	0.88	0.94
EV/EBITDA Ratio	12.73	11.22	9.97	11.48	14.51	13.29
EV/EBIT Ratio	13.91	12.22	10.64	12.71	16.35	14.49
EV/FCF Ratio	16.85	31.96	23.05	18.58	19.10	17.98

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.69	0.74	0.78	0.66	0.69	0.67
Debt / EBITDA Ratio	3.67	3.57	3.01	2.34	2.58	2.37
Debt / FCF Ratio	4.94	10.32	7.07	3.84	3.46	3.30
Net Debt / Equity Ratio	0.46	0.53	0.58	0.49	0.49	0.53
Net Debt / EBITDA Ratio	2.50	2.57	2.27	1.78	1.85	1.95
Net Debt / FCF Ratio	3.31	7.33	5.25	2.87	2.44	2.63
Quick Ratio	1.37	1.41	1.32	1.30	1.27	1.33
Current Ratio	1.52	1.54	1.45	1.44	1.40	1.47
Asset Turnover	1.62	1.67	1.57	1.62	1.56	1.51
Return on Equity (ROE)	11.13%	13.25%	14.77%	15.82%	16.25%	17.74%
Return on Assets (ROA)	3.83%	4.35%	5.46%	5.84%	5.28%	6.13%
Return on Invested Capital (ROIC)	8.46%	9.31%	10.72%	12.12%	10.79%	12.14%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	5.83%	7.27%	6.99%	5.40%	4.81%	5.47%
FCF Yield	7.39%	4.07%	5.32%	6.11%	5.92%	6.47%
Dividend Yield	1.75%	1.97%	1.82%	1.31%	1.05%	1.04%
Payout Ratio	30.61%	27.00%	25.22%	23.30%	20.85%	17.93%
Buyback Yield / Dilution	3.64%	3.56%	1.90%	2.22%	1.62%	2.95%
Total Shareholder Return	5.39%	5.54%	3.72%	3.53%	2.68%	3.99%

SEC Filings: 10-K · 10-Q